TCL Archive NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period October 18, 1985
TCL Archive GPC Biotech’s Satraplatin Fails To Extend Survival In Hormone-Refractory Prostate Cancer. November 2, 2007